LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock

INTRODUCTION: Sepsis is a life-threatening, dysregulated response to infection. Both high-density lipoprotein and low-density lipoprotein cholesterol should protect against sepsis by several mechanisms; however, for partially unknown reasons, cholesterol levels become critically low in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Guirgis, Faheem W, Black, Lauren Page, Rosenthal, Martin Daniel, Henson, Morgan, Ferreira, Jason, Leeuwenburgh, Christiaan, Kalynych, Colleen, Moldawer, Lyle L, Miller, Taylor, Jones, Lisa, Crandall, Marie, Reddy, Srinivasa T, Wu, Samuel S, Moore, Frederick A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756323/
https://www.ncbi.nlm.nih.gov/pubmed/31537565
http://dx.doi.org/10.1136/bmjopen-2019-029348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756323/
https://www.ncbi.nlm.nih.gov/pubmed/31537565
http://dx.doi.org/10.1136/bmjopen-2019-029348

Ejemplares similares